Publikationen in Zusammenarbeit mit Forschern von Massachusetts General Hospital (31)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Efficacy and acceptability of psychosocial interventions in schizophrenia: systematic overview and quality appraisal of the meta-analytic evidence

    Molecular Psychiatry, Vol. 28, Núm. 1, pp. 354-368

  3. Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations

    Nature genetics, Vol. 55, Núm. 3, pp. 369-376

2022

  1. Effects of copy number variations on brain structure and risk for psychiatric illness: Large-scale studies from the ENIGMA working groups on CNVs

    Human Brain Mapping, Vol. 43, Núm. 1, pp. 300-328

  2. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

  3. NSCLC Subtyping in Conventional Cytology: Results of the International Association for the Study of Lung Cancer Cytology Working Group Survey to Determine Specific Cytomorphologic Criteria for Adenocarcinoma and Squamous Cell Carcinoma

    Journal of Thoracic Oncology, Vol. 17, Núm. 6, pp. 793-805

  4. Pimavanserin for negative symptoms of schizophrenia: results from the ADVANCE phase 2 randomised, placebo-controlled trial in North America and Europe

    The Lancet Psychiatry, Vol. 9, Núm. 1, pp. 46-58

  5. Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology Committee

    Journal of Thoracic Oncology, Vol. 17, Núm. 12, pp. 1335-1354

  6. Psychosis as a Treatment Target in Dementia: A Roadmap for Designing Interventions

    Journal of Alzheimer's disease : JAD, Vol. 88, Núm. 4, pp. 1203-1228

  7. Rare coding variation provides insight into the genetic architecture and phenotypic context of autism

    Nature Genetics, Vol. 54, Núm. 9, pp. 1320-1331

2021

  1. Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel

    Alzheimer's and Dementia, Vol. 17, Núm. 9, pp. 1528-1553

  2. The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC

    Journal of Thoracic Oncology, Vol. 16, Núm. 4, pp. 686-696

2020

  1. Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism

    Cell, Vol. 180, Núm. 3, pp. 568-584.e23

  2. PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee

    Journal of Thoracic Oncology, Vol. 15, Núm. 4, pp. 499-519

  3. Resting-state connectivity and network parameter analysis in alcohol-dependent males. A simultaneous EEG-MEG study

    Journal of Neuroscience Research, Vol. 98, Núm. 10, pp. 1857-1876

  4. Sensory-to-Cognitive Systems Integration Is Associated With Clinical Severity in Autism Spectrum Disorder

    Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 59, Núm. 3, pp. 422-433

  5. The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee

    Journal of Thoracic Oncology, Vol. 15, Núm. 9, pp. 1409-1424

2019

  1. A N400 ERP Study in letter recognition after passive tactile stimulation training in blind children and sighted controls

    Restorative Neurology and Neuroscience, Vol. 37, Núm. 3, pp. 197-206

  2. Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer

    Journal of Thoracic Oncology, Vol. 14, Núm. 3, pp. 377-407

  3. ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research

    Annals of Oncology, Vol. 30, Núm. 9, pp. 1417-1427